BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

  April 3, 2025

   · 

  4 min read
• Press Releases

  Curis to Present at Upcoming Healthcare Conference in April 2025

  April 3, 2025

   · 

  1 min read
• Press Releases

  Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2025

  April 3, 2025

   · 

  1 min read
• Press Releases

  Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome

  April 3, 2025

   · 

  8 min read
• Press Releases

  Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

  April 3, 2025

   · 

  21 min read
• Press Releases

  RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

  April 3, 2025

   · 

  6 min read
• Press Releases

  Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum

  April 3, 2025

   · 

  4 min read
• Press Releases

  Novo Nordisk announces changes in Executive Management

  April 3, 2025

   · 

  2 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report

  April 3, 2025

   · 

  3 min read
• Press Releases

  Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors

  April 3, 2025

   · 

  5 min read